Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,084 across all filing types
Latest filing 2023-09-14 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more during a takeover or merger situation. This falls under the category of 'Major Shareholding Notification' as it reports significant ownership levels and changes in holdings related to an offeror/offeree (Horizon Therapeutics PLC).
2023-09-14 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a mandatory regulatory filing under the UK Takeover Code. It details the opening position and dealing disclosures of a person with interests in relevant securities representing 1% or more of a company involved in a takeover (Network International Holdings PLC). This type of document is a standard regulatory disclosure regarding shareholdings and dealings during an M&A process, which falls under the 'Regulatory Filings' (RNS) category as it is a specific regulatory announcement distributed via the London Stock Exchange's RNS service.
2023-09-14 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the securities of an offeror or offeree during a takeover period. Since this document details major shareholding positions and dealings related to a takeover, it falls under the category of Major Shareholding Notification (MRQ).
2023-09-13 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act for persons with interests in relevant securities representing 1% or more during a takeover. It details shareholdings, derivatives, and dealings in Horizon Therapeutics PLC by Citadel Group. As this is a specific regulatory disclosure form regarding major shareholding and takeover-related activity, it falls under the 'Major Shareholding Notification' category.
2023-09-12 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more. This type of disclosure is specifically used to report major shareholding changes and market activity during takeover situations. Since it does not fit into the specific categories of 'Major Shareholding Notification' (which usually refers to TR-1 filings) or 'Director's Dealing', and is a standard regulatory requirement for market transparency, it is classified as a Regulatory Filing (RNS).
2023-09-12 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Horizon Therapeutics PLC). This type of regulatory disclosure regarding significant shareholding and derivative positions during a takeover process falls under the 'Major Shareholding Notification' category.
2023-09-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.